GERD clinical trials at UCSF
1 in progress, 0 open to eligible people
Dexlansoprazole Delayed-Release Capsules to Treat Symptomatic Nonerosive Gastroesophageal Reflux Disease in Children
Sorry, not currently recruiting here
The main aims of the study are to see the - side effects of Dexlansoprazole treatment - effectiveness of Dexlansoprazole treatment in children having symptomatic nonerosive gastroesophageal reflux disease (GERD). Participants will take Dexlansoprazole by mouth once daily for 12 weeks
San Francisco, California and other locations
Our lead scientists for GERD research studies include Yvette Wild.